IPSCNasdaq United States
Market cap
$360.710 M
$2.00 +5.26%
Close of 7 Aug 2026
Revenue
$109.2M
#2488 by revenue
Earnings
-$9.58M
Loss-making
Shares outstanding
180,354,809
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Century Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.